ICD-10 Code C81.28 | Mixed cellular Hodgkin lymphoma, nodes mult site Symptoms, Diagnosis, Billing

Mixed cellular Hodgkin lymphoma, nodes mult site is a subtype of Hodgkin lymphoma characterized by the presence of mixed cellularity in lymph nodes at multiple sites. This condition is clinically significant due to its potential for systemic symptoms and requires accurate coding for effective diagnosis, treatment planning, and reimbursement processes. The ICD-10 Code C81.28 facilitates precise documentation and billing, ensuring compliance with healthcare regulations and supporting public health data collection.

What is ICD-10 Code C81.28 for Mixed cellular Hodgkin lymphoma, nodes mult site?

ICD-10 Code C81.28 represents Mixed cellular Hodgkin lymphoma affecting multiple lymph node sites. This condition is marked by a heterogeneous population of cells within the lymph nodes, leading to various clinical manifestations. The code is utilized in clinical documentation and billing when diagnosing patients with this specific subtype of Hodgkin lymphoma, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.

ICD-10 Code C81.28 – Clinical Definition and Explanation of Mixed cellular Hodgkin lymphoma, nodes mult site

Mixed cellular Hodgkin lymphoma, nodes mult site is caused by the proliferation of atypical lymphoid cells within lymph nodes, leading to lymphadenopathy and systemic symptoms. The disease can progress to involve multiple lymphatic regions and requires prompt medical intervention to manage symptoms and prevent complications.

Key Clinical Features:

• Presence of lymphadenopathy in multiple regions.
• Systemic symptoms such as fever, night sweats, and weight loss.
• Histological confirmation of mixed cellularity in lymph node biopsy.
• Potential for splenic and extranodal involvement.

ICD-10 Code C81.28 for Mixed cellular Hodgkin lymphoma, nodes mult site – SOAP Notes & Clinical Use

ICD-10 Code C81.28 is integral in SOAP notes for documenting the patient's symptoms, assessment findings, and treatment plans. It aids in capturing the complexity of the condition in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.

What Does ICD-10 Code C81.28 for Mixed cellular Hodgkin lymphoma, nodes mult site Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C81.28 connects subjective patient reports and objective clinical findings to a formal diagnosis of Mixed cellular Hodgkin lymphoma. This code is essential for maintaining continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C81.28 – Mixed cellular Hodgkin lymphoma, nodes mult site

Management of Mixed cellular Hodgkin lymphoma, nodes mult site often necessitates hospitalization for intensive treatment. Chemotherapy is the primary treatment modality, and supportive care is crucial for symptom management.

Antibiotic Therapy:

• Not applicable as this is not an infectious condition.

Supportive Care:

• Management of symptoms such as pain and fever.
• Nutritional support to maintain strength.
• Psychosocial support for emotional well-being.

Infection Control:

• Standard precautions to prevent infection.
• Monitoring for signs of infection due to immunosuppression.

How to Document Symptoms of Mixed cellular Hodgkin lymphoma, nodes mult site (ICD-10 C81.28) in SOAP Notes

Subjective:

• Patient reports persistent lymphadenopathy in neck and axilla.
• Experiencing night sweats and unintentional weight loss.
• Complains of fatigue and generalized weakness.

Objective:

• Physical examination reveals enlarged lymph nodes in multiple regions.
• Vital signs: temperature 100.5°F, heart rate 88 bpm.
• Laboratory tests show elevated lactate dehydrogenase (LDH) levels.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Mixed cellular Hodgkin lymphoma, nodes mult site (ICD-10 Code C81.28)

Assessment:

• Diagnosis: Mixed cellular Hodgkin lymphoma, nodes mult site, moderate severity.
• ICD-10 Code: C81.28.
• Contributing factors include age and gender predisposition.

Plan:

• Initiate chemotherapy regimen as per oncology guidelines.
• Schedule follow-up appointments for monitoring treatment response.
• Educate patient on potential side effects and supportive measures.

Treatment & Plan Section for ICD-10 Code C81.28 – Mixed cellular Hodgkin lymphoma, nodes mult site

• First-line treatment includes ABVD chemotherapy regimen.
• Non-pharmacologic strategies include nutritional counseling and exercise as tolerated.
• Monitoring includes regular imaging studies to assess treatment response.
• Follow-up practices involve hematology-oncology consultations every 3 months.

Using ICD-10 Code C81.28 for Mixed cellular Hodgkin lymphoma, nodes mult site in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical documentation of the condition.
• Ensure Subjective (S) and Objective (O) sections reflect the patient's symptoms and findings.
• Align treatment plans with clinical guidelines to support justified billing.
• Document all relevant CPT codes that correspond with the services provided.

Related ICD-10 Codes Often Used with Mixed cellular Hodgkin lymphoma, nodes mult site

ICD-10 Code C81.28 in Medical Billing and Insurance for Mixed cellular Hodgkin lymphoma, nodes mult site

ICD-10 Code C81.28 is crucial for accurate billing in hospital, ER, or oncology settings, ensuring proper reimbursement for services rendered.

Billing Notes:

• Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
• Use this code in inpatient and outpatient settings where the diagnosis is confirmed.
• Ensure that all documentation aligns with coding guidelines to avoid claim denials.

Common CPT Pairings: